COVID-19 vaccination provides protection against serious illness and outcomes associated with COVID-19, including emergency department or urgent care visits, hospitalizations, and death. The Novavax COVID-19 vaccine is the first COVID-19 protein subunit vaccine recommended for use in the United States that is built on a familiar type of vaccine technology. Other protein subunit vaccines have been used for more than 30 years in the United States, including for hepatitis B, HPV, and acellular pertussis (whooping cough) vaccines. During this COCA Call, presenters will discuss CDC’s new guidance on the Novavax COVID-19 vaccine for adults ages 18 years and older, including adults who are moderately or severely immunocompromised.

When: Thursday, July 28, 2022, 2:00 PM – 3:00 PM ET

Webinar Link: https://www.zoomgov.com/j/1612728470

Passcode: 663869

Dial In:
US: +1 669 254 5252
or +1 646 828 7666
or +1 551 285 1373
or +1 669 216 1590

One-tap mobile: US: +16692545252,,1612728470#,,,,*663869#  or +16468287666,,1612728470#,,,,*663869#

Webinar ID: 161 272 8470